Emma Searle

1.3k total citations
28 papers, 359 citations indexed

About

Emma Searle is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Emma Searle has authored 28 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 14 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Emma Searle's work include Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (11 papers) and Histone Deacetylase Inhibitors Research (5 papers). Emma Searle is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (11 papers) and Histone Deacetylase Inhibitors Research (5 papers). Emma Searle collaborates with scholars based in United Kingdom, United States and Spain. Emma Searle's co-authors include Debra Breneman, Natalie Cook, Sana Saleem, Ian J. Stratford, Tim Illidge, Cyrille Touzeau, Jesús G. Berdeja, Sébastien Anguille, Deeksha Vishwamitra and Hang Quach and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American Academy of Dermatology.

In The Last Decade

Emma Searle

25 papers receiving 346 citations

Peers

Emma Searle
Lívia Beke Hungary
Caterina Baldi Italy
Yoshihiro Komuro Japan
Guocan Yang China
Sandra Sapia Argentina
Steve Abella United States
S.D. Nandedkar United States
Franziska Trautmann Germany
Serghei Popa Moldova
John R. Weis United States
Lívia Beke Hungary
Emma Searle
Citations per year, relative to Emma Searle Emma Searle (= 1×) peers Lívia Beke

Countries citing papers authored by Emma Searle

Since Specialization
Citations

This map shows the geographic impact of Emma Searle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Searle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Searle more than expected).

Fields of papers citing papers by Emma Searle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Searle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Searle. The network helps show where Emma Searle may publish in the future.

Co-authorship network of co-authors of Emma Searle

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Searle. A scholar is included among the top collaborators of Emma Searle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Searle. Emma Searle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeidan, Amer M., Anthony S. Stein, Johanna Rimpiläinen, et al.. (2025). Efficacy, molecular and translational analysis of TP53-mutated HR-MDS with bexmarilimab and azacitidine: Updated results from the bexmab Phase 1/2 study. Blood. 146(Supplement 1). 236–236. 1 indexed citations
2.
3.
Baljević, Muhamed, Peter M. Voorhees, Anita D’Souza, et al.. (2025). Long-term efficacy and safety of etentamig, a B-cell maturation antigen (BCMA) bispecific antibody in patients with relapsed/refractory multiple myeloma (RRMM).. Journal of Clinical Oncology. 43(16_suppl). 7527–7527. 2 indexed citations
4.
Watts, Justin M., Alessandro M. Vannucchi, Anthony M. Hunter, et al.. (2024). Bromodomain and extra-terminal (BET) inhibitor INCB057643 in patients with relapsed or refractory myelofibrosis (MF) and other advanced myeloid neoplasms: A phase 1 study.. Journal of Clinical Oncology. 42(16_suppl). 6576–6576. 1 indexed citations
5.
Jackson, Christopher, Ahmed M. Soliman, Anthony K.C. Chan, et al.. (2024). Patient Experiences of Using Wearable Health Monitors During Cancer Treatment: A Qualitative Study. Clinical Oncology. 37. 103664–103664.
6.
7.
Searle, Emma, Francesco Forconi, Kim Linton, et al.. (2023). Initial Findings from a First-in-Human Phase 1a/b Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients with Relapsed/Refractory B Cell Malignancies. Blood. 142(Supplement 1). 4473–4473. 23 indexed citations
8.
9.
Saleem, Sana, et al.. (2022). Targeting hypoxia in solid and haematological malignancies. Journal of Experimental & Clinical Cancer Research. 41(1). 318–318. 36 indexed citations
10.
Brooks, Nigel, Fabio M. R. Amaral, Neil Pegg, et al.. (2022). Potent Pre-Clinical and Early Phase Clinical Activity of EP300/CBP Bromodomain Inhibitor CCS1477 in Multiple Myeloma. Blood. 140(Supplement 1). 852–853. 6 indexed citations
11.
12.
Batta, Kiran, et al.. (2021). The Dynamic Interface Between the Bone Marrow Vascular Niche and Hematopoietic Stem Cells in Myeloid Malignancy. Frontiers in Cell and Developmental Biology. 9. 20 indexed citations
13.
Searle, Emma, Brian A. Telfer, Debayan Mukherjee, et al.. (2017). Akt inhibition improves long‐term tumour control following radiotherapy by altering the microenvironment. EMBO Molecular Medicine. 9(12). 1646–1659. 12 indexed citations
14.
Searle, Emma, et al.. (2017). How to make Balint groups relevant for mental health nurses. Mental Health Practice. 21(2). 18–21. 2 indexed citations
15.
Sinclair, Julia & Emma Searle. (2016). Can student health professionals accurately estimate alcohol content in commonly occurring drinks?. Therapeutic Advances in Psychopharmacology. 6(4). 256–262. 5 indexed citations
16.
Searle, Emma, Tim Illidge, & Ian J. Stratford. (2014). Emerging Opportunities for the Combination of Molecularly Targeted Drugs with Radiotherapy. Clinical Oncology. 26(5). 266–276. 12 indexed citations
17.
Searle, Emma, B. Nausheen, & Julia Sinclair. (2009). Estimating the alcohol content of commonly consumed beverages: knowing the “standard drink". Annals of Medicine. 38(6). 389–402. 1 indexed citations
18.
Searle, Emma, Hitendra Patel, F. Javier Vilar, et al.. (2009). Inflammatory BCG adenitis associated with immune reconstitution following allogeneic haematopoietic stem cell transplant in infancy. Pediatric Blood & Cancer. 54(1). 166–169. 11 indexed citations
19.
Searle, Emma, Sue Pavord, & Žarko Alfirević. (2008). Recombinant factor VIIa and other pro-haemostatic therapies in primary postpartum haemorrhage. Best Practice & Research Clinical Obstetrics & Gynaecology. 22(6). 1075–1088. 11 indexed citations
20.
Breneman, Debra, et al.. (1992). Topical capsaicin for treatment of hemodialysis-related pruritus. Journal of the American Academy of Dermatology. 26(1). 91–94. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lívia Beke Breakdown of academic impact, for papers by Caterina Baldi Breakdown of academic impact, for papers by Yoshihiro Komuro Breakdown of academic impact, for papers by Guocan Yang Breakdown of academic impact, for papers by Sandra Sapia Breakdown of academic impact, for papers by Steve Abella Breakdown of academic impact, for papers by S.D. Nandedkar Breakdown of academic impact, for papers by Franziska Trautmann Breakdown of academic impact, for papers by Serghei Popa Breakdown of academic impact, for papers by John R. Weis
Rankless by CCL
2026